{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:17:17Z","timestamp":1791307037120,"version":"4.3.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.actatropica.2008.02.001","type":"journal-article","created":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T12:28:33Z","timestamp":1203510513000},"page":"104-108","source":"Crossref","is-referenced-by-count":37,"title":["Artesunate\u2013erythropoietin combination for murine cerebral malaria treatment"],"prefix":"10.1016","volume":"106","author":[{"given":"Anne-Lise","family":"Bienvenu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josette","family":"Ferrandiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Picot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2008.02.001_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.qco.0000186848.46417.6c","article-title":"Artemisinin-based combinations","volume":"18","author":"Ashley","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2008.02.001_bib2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/AAC.01313-06","article-title":"Comparison of a SYBR Green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates","volume":"51","author":"Bacon","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2008.02.001_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11940-004-0022-7","article-title":"Cerebral malaria","volume":"6","author":"Birbeck","year":"2004","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrn1687","article-title":"Emerging biological roles for erythropoietin in the nervous system","volume":"6","author":"Brines","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.actatropica.2008.02.001_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.ki.5001546","article-title":"Discovering erythropoietin's extra-hematopoietic functions, biology and clinical promise","volume":"70","author":"Brines","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.actatropica.2008.02.001_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.bjp.0707161","article-title":"Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity","volume":"150","author":"Chong","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1567202043480116","article-title":"Cerebral malaria \u2013 a neurovascular pathology with many riddles still to be solved","volume":"1","author":"Coltel","year":"2004","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.actatropica.2008.02.001_bib8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/infdis\/171.5.1317","article-title":"Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children","volume":"171","author":"Di Perri","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2008.02.001_bib9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.arcped.2006.09.010","article-title":"Management of children severe malaria in Tsevie's (Togo) hospital regional center","volume":"13","author":"Djadou","year":"2006","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.actatropica.2008.02.001_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"Dondorp","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2008.02.001_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002","journal-title":"Mol. Med."},{"key":"10.1016\/j.actatropica.2008.02.001_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/B:MEBR.0000043969.96895.3c","article-title":"Erythropoietin: novel approaches to neuroprotection in human brain disease","volume":"19","author":"Ehrenreich","year":"2004","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.actatropica.2008.02.001_bib13","first-page":"103","article-title":"Experimental models of cerebral malaria","volume":"297","author":"Engwerda","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib14","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0409329102","article-title":"A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury","volume":"102","author":"Fiordaliso","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.actatropica.2008.02.001_bib15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1086\/430180","article-title":"Neurotoxicity due to antimalarial therapy associated with misdiagnosis of malaria","volume":"40","author":"Franco-Paredes","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2008.02.001_bib16","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1038\/sj.cdd.4401450","article-title":"Erythropoietin as an antiapoptotic, tissue-protective cytokine","volume":"11","author":"Ghezzi","year":"2004","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.actatropica.2008.02.001_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijpara.2006.02.009","article-title":"Conventional and experimental treatment of cerebral malaria","volume":"36","author":"Golenser","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ijpara.2006.07.011","article-title":"Current perspectives on the mechanism of action of artemisinins","volume":"36","author":"Golenser","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib19","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.3306918","article-title":"Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria","volume":"237","author":"Grau","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2008.02.001_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1383-5769(02)00081-8","article-title":"Oral artesunate prevents Plasmodium berghei Anka infection in mice","volume":"52","author":"Gumede","year":"2003","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.actatropica.2008.02.001_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00008506-200604000-00007","article-title":"The brain erythropoietin system and its potential for therapeutic exploitation in brain disease","volume":"18","author":"Hasselblatt","year":"2006","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/infdis\/174.5.1091","article-title":"The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria","volume":"174","author":"van Hensbroek","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2008.02.001_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1474-4422(05)70247-7","article-title":"Pathogenesis, clinical features, and neurological outcome of cerebral malaria","volume":"4","author":"Idro","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1179\/136485906X91459","article-title":"Research priorities in the management of severe Plasmodium falciparum malaria in children","volume":"100","author":"Idro","year":"2006","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000074970","article-title":"Erytropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin","volume":"85","author":"Juul","year":"2004","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.actatropica.2008.02.001_bib26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1086\/500844","article-title":"Recombinant human erythropoietin prevents the death of mice during cerebral malaria","volume":"193","author":"Kaiser","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2008.02.001_bib27","first-page":"1097","article-title":"Establishment of artemisinin combination therapy as first line treatment for combating malaria. Artemisia annua cultivation in India needed for providing sustainable supply chain of artemisinin","volume":"89","author":"Kumar","year":"2005","journal-title":"Curr. Sci."},{"key":"10.1016\/j.actatropica.2008.02.001_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2008.02.001_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000081963","article-title":"Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways","volume":"13","author":"Li","year":"2004","journal-title":"Neurosignals"},{"key":"10.1016\/j.actatropica.2008.02.001_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10915810591007201","article-title":"Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats","volume":"24","author":"Li","year":"2005","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/CMR.14.4.810-820.2001","article-title":"Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans","volume":"14","author":"Lou","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2008.02.001_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1440-1681.2003.03927.x","article-title":"Neurocardiovascular regulation in mice: experimental approaches and novel findings","volume":"30","author":"Ma","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.pt.2004.09.006","article-title":"Clinical features and pathogenesis of severe malaria","volume":"20","author":"Mackintosh","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2008.02.001_bib34","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1046\/j.1460-9568.2003.02987.x","article-title":"Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability","volume":"18","author":"Martinez-Estrada","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.actatropica.2008.02.001_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00023210-200317030-00002","article-title":"Cerebral malaria: optimising management","volume":"17","author":"Mturi","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.actatropica.2008.02.001_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(98)00008-4","article-title":"Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment","volume":"79","author":"Newton","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.actatropica.2008.02.001_bib37","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.44.4.972-977.2000","article-title":"Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria","volume":"44","author":"Newton","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2008.02.001_bib38","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1086\/498033","article-title":"Misattribution of central nervous system dysfunction to artesunate","volume":"41","author":"Newton","year":"2005","journal-title":"CID"},{"key":"10.1016\/j.actatropica.2008.02.001_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.micinf.2004.02.007","article-title":"Risk factors for severe malaria in Bamako, Mali: a matched case\u2013control study","volume":"6","author":"Safeukui-Noubissi","year":"2004","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2008.02.001_bib40","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.051606598","article-title":"Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress","volume":"98","author":"Siren","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.actatropica.2008.02.001_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1286-4579(02)01541-1","article-title":"Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis","volume":"4","author":"de Souza","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2008.02.001_bib42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/AAC.48.3.954-960.2004","article-title":"Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum","volume":"48","author":"Teja-Isavadharm","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2008.02.001_bib43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0035-9203(98)90753-2","article-title":"Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria","volume":"92","author":"Thuma","year":"1998","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2008.02.001_bib44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2008.02.001_bib45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20021067","article-title":"Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis","volume":"198","author":"Villa","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actatropica.2008.02.001_bib46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.jcbfm.9600370","article-title":"Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives","volume":"27","author":"Villa","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.actatropica.2008.02.001_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11908-006-0032-6","article-title":"Parenteral artesunate for treatment of severe malaria","volume":"8","author":"Wilson","year":"2006","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.actatropica.2008.02.001_bib48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/10915810591007229","article-title":"Risk assessment and therapeutic indices of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats","volume":"24","author":"Xie","year":"2005","journal-title":"Int. J. Toxicol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X08000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X08000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T04:39:41Z","timestamp":1557290381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X08000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0001706X08000442"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2008.02.001","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}